Patrick Grace Sells 190 Shares of Chemed (NYSE:CHE) Stock

Posted by Francis Steltz on Aug 5th, 2026

Chemed Corporation (NYSE:CHE – Get Free Report) Director Patrick Grace sold 190 shares of the business’s stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the sale, the director directly owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. The trade was a 5.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Chemed Price Performance

Shares of Chemed stock opened at $539.13 on Wednesday. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $7.05 billion, a price-to-earnings ratio of 27.08, a price-to-earnings-growth ratio of 2.05 and a beta of 0.51. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $551.68. The company has a 50-day simple moving average of $471.15 and a two-hundred day simple moving average of $437.76.

Chemed (NYSE:CHE – Get Free Report) last announced its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. The firm had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The business’s revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Analysts forecast that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio is presently 12.05%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Commonwealth Equity Services LLC raised its position in Chemed by 3.1% during the 4th quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after purchasing an additional 22 shares during the last quarter. Cim LLC increased its position in Chemed by 1.1% during the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock valued at $958,000 after purchasing an additional 24 shares during the period. Eukles Asset Management raised its holdings in Chemed by 0.4% during the 4th quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock worth $2,591,000 after purchasing an additional 25 shares during the last quarter. MassMutual Private Wealth & Trust FSB lifted its position in shares of Chemed by 65.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock worth $38,000 after purchasing an additional 32 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Chemed by 9.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock worth $153,000 after purchasing an additional 35 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Royal Bank Of Canada upped their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Bank of America reiterated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $530.75.

Read Our Latest Research Report on CHE

Chemed Company Profile

(Get Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.